Found: 8
Select item for more details and to access through your institution.
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.595804
- By:
- Publication type:
- Article
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 7, p. 979, doi. 10.1093/jnci/djac057
- By:
- Publication type:
- Article
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction.
- Published in:
- Journal of Pathology, 2012, v. 226, n. 3, p. 482, doi. 10.1002/path.2998
- By:
- Publication type:
- Article
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6085, doi. 10.3390/cancers13236085
- By:
- Publication type:
- Article
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1841, doi. 10.3390/cancers12071841
- By:
- Publication type:
- Article
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e220130, doi. 10.1001/jamanetworkopen.2022.0130
- By:
- Publication type:
- Article